LILRB1 and non-small cell lung carcinoma: Immunologic analyses from the LCMC3 trial revealed that lower frequencies of ILT2+NKG2A+ and ILT2+NKG2A NK cells, and ILT2+ NK-like T cells were strongly associated with MPR in NSCLC patients (73).